{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:21:54Z","timestamp":1784542914413,"version":"3.55.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008734","name":"Lyfjafr\u00e6\u00f0ingaf\u00e9lags \u00cdslands","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008734","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> The risk of mortality associated with the co-prescribing of benzodiazepines and opioids has been explored in a number of papers mainly focusing on strong opioids. The mortality risk associated with the use of weak opioids has not been dealt with to a similar extent.<\/jats:p><jats:p><jats:bold>Objective:<\/jats:bold> To assess the mortality risk in primary care patients with consistent 3-year co-prescribing of benzodiazepine\/Z-drugs (benzodiazepine receptor modulators) and mainly weak opioids (codeine, tramadol).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Of 221,804 patients contacting the primary healthcare centres, 124,436 were selected for further analysis, 88,832 participants fulfilled the inclusion criteria, aged 10\u201369\u00a0years and were divided into four groups with neither any use of benzodiazepines\/Z-drugs nor opioids as Group 1, 3\u00a0years\u2019 use of opioids and no\/minimal benzodiazepines\/Z-drugs as Group 2, with benzodiazepines\/Z-drugs and no\/minimal opioids as Group 3, and finally both benzodiazepines\/Z-drugs and opioids as Group 4. Hazard ratios were calculated with the no-drug group as a reference, using Cox proportional hazards regression model adjusted for age, sex, number of chronic conditions and cancer patients excluded (n = 87,314).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Hazard ratios for mortality increased both in Group 3 where it was 2.66 (95% CI 2.25\u20133.09) and in Group 4 where it was 5.12 (95% CI 4.25\u20136.17), with increased dose and higher number of chronic conditions. In Group 4 an opioid dose-dependent increase in mortality among persons using &amp;gt;1000 DDDs benzodiazepines\/Z-drugs was observed when those on less than \u2264300 DDDs of opioids with HR 4.94 (95% CI 3.54\u20136.88) were compared to those on &amp;gt;300 DDDs with HR 7.61\/95% CI 6.08\u20139.55). This increase in mortality was not observed among patients on &amp;lt;1000 DDDs of benzodiazepines\/Z-drugs.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The study supports evidence suggesting that mortality increases in a dose-dependent manner in patients co-prescribed benzodiazepines\/Z-drugs and weak opioids (codeine, tramadol). An association between the number of chronic conditions and a rise in mortality was found. Long-term use of these drugs should preferably be avoided. Non-pharmacological therapy should be seriously considered instead of long-term use of benzodiazepines\/Z-drugs, and deprescribing implemented for chronic users of these drugs when possible.<\/jats:p>","DOI":"10.3389\/fphar.2022.932380","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T08:56:46Z","timestamp":1662454606000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Co-prescribing of opioids and benzodiazepines\/Z-drugs associated with all-cause mortality\u2014A population-based longitudinal study in primary care with weak opioids most commonly prescribed"],"prefix":"10.3389","volume":"13","author":[{"given":"Kristjan","family":"Linnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidrun Sjofn","family":"Thorsteinsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann Agust","family":"Sigurdsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil Larus","family":"Sigurdsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larus Steinthor","family":"Gudmundsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1513\/AnnalsATS.201901-024OC","article-title":"Association of opioid and benzodiazepine use with adverse respiratory events in older adults with chronic obstructive pulmonary disease","volume":"16","author":"Baillargeon","year":"2019","journal-title":"Ann. Am. Thorac. Soc."},{"key":"B2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.sleep.2015.12.004","article-title":"Zolpidem use and motor vehicle collisions in older drivers","volume":"20","author":"Booth","year":"2016","journal-title":"Sleep. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0238285","DOI":"10.1371\/journal.pone.0238285","article-title":"Increased risk of adverse events in non-cancer patients with chronic and high-dose opioid use \u2013 A health insurance claims analysis","volume":"15","author":"Burgstaller","year":"2020","journal-title":"PLoS One"},{"key":"B5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12888-019-2312-3","article-title":"Association between benzodiazepines and suicide risk: A matched case-control study","volume":"19","author":"Cato","year":"2019","journal-title":"BMC Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/bcp.15028","article-title":"Association between opioid-related deaths and persistent opioid prescribing in primary care in england: A nested case-control study","volume":"88","author":"Chen","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ejp.1291","article-title":"Prescription opioid analgesic use in France: Trends and impact on morbidity\u2013mortality","volume":"23","author":"Chenaf","year":"2019","journal-title":"Eur. J. Pain"},{"key":"B8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S2215-0366(18)30471-1","article-title":"Opioid prescribing trends and geographical variation in england, 1998\u20132018: A retrospective database study","volume":"8","author":"Curtis","year":"2019","journal-title":"Lancet. Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/bmj.313.7053.321","article-title":"Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: A systematic review","volume":"313","author":"de Craen","year":"1996","journal-title":"BMJ"},{"key":"B10","unstructured":"\u00der\u00f3un \u00ed notkun \u00f3p\u00ed\u00f3\u00ed\u00f0a [Development in the use of opioids]2021"},{"key":"B11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1071\/AH18245","article-title":"Trends in opioid prescribing in Australia: A systematic review","volume":"44","author":"Donovan","year":"2020","journal-title":"Aust. Health Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.36076\/ppj.2018.3.219","article-title":"Patterns, changes, and trends in prescription opioid dispensing in Canada, 2005-2016","volume":"21","author":"Fischer","year":"2018","journal-title":"Pain. Phys."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1212\/WNL.0000000000000839","article-title":"Opioids for chronic noncancer pain: A position paper of the American Academy of Neurology","volume":"83","author":"Franklin","year":"2014","journal-title":"Neurology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12916-020-01644-4","article-title":"All-cause mortality in patients with long-term opioid therapy compared with non-opioid analgesics for chronic non-cancer pain: A database study","volume":"18","author":"H\u00e4user","year":"2020","journal-title":"BMC Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e599","DOI":"10.1097\/PR9.0000000000000599","article-title":"The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain: A perspective from different continents","volume":"2","author":"H\u00e4user","year":"2017","journal-title":"Pain Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"612556","DOI":"10.3389\/fphar.2020.612556","article-title":"Increasing trends in opioid use from 2010 to 2018 in the region of valencia, Spain: A real world, population-based study","volume":"11","author":"Hurtardo","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s40264-018-00786-y","article-title":"All-cause mortality associated with tramadol use: A case-crossover study","volume":"42","author":"Jeong","year":"2019","journal-title":"Drug Saf."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1016\/j.amjmed.2022.02.039","article-title":"Opioid and benzodiazepine substitutes: Impact on drug overdose mortality in medicare population","volume":"135","author":"Kuo","year":"2022","journal-title":"Am. J. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/pds.3776","article-title":"Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001-2010","volume":"24","author":"Larochelle","year":"2015","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12875-016-0469-0","article-title":"Multimorbidity and use of hypnotic and anxiolytic drugs: Cross-sectional and follow-up study in primary healthcare in Iceland","volume":"17","author":"Linnet","year":"2016","journal-title":"BMC Fam. Pract."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e033545","DOI":"10.1136\/bmjopen-2019-033545","article-title":"Association between prescription of hypnotics\/anxiolytics and mortality in multimorbid and non-multimorbid patients: A longitudinal cohort study in primary care","volume":"9","author":"Linnet","year":"2019","journal-title":"BMJ Open"},{"key":"B23","doi-asserted-by":"publisher","first-page":"100388","DOI":"10.1016\/j.ssmph.2019.100388","article-title":"The medicalization of sleeplessness: Results of U.S. Office visit outcomes, 2008\u20132015","volume":"8","author":"Moloney","year":"2019","journal-title":"SSM Popul. Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.2105\/AJPH.2010.300014","article-title":"The medicalization of sleeplessness: A public health concern","volume":"101","author":"Moloney","year":"2011","journal-title":"Am. J. Public Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/ADM.0000000000000828","article-title":"Association between benzodiazepine and opioid prescription and mortality among patients in a large healthcare system","volume":"16","author":"Mooney","year":"2022","journal-title":"J. Addict. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40801-019-00163-w","article-title":"Trends of opioid utilisation in Denmark: A nationwide study","volume":"6","author":"Nissen","year":"2019","journal-title":"Drugs Real World Outcomes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/thoraxjnl-2012-202374","article-title":"The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: A nested case-control and survival analysis in a population-based cohort","volume":"68","author":"Obiora","year":"2013","journal-title":"Thorax"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.sapharm.2020.09.007","article-title":"Fracture risk increased by concurrent use of central nervous system agents in older people: Nationwide case-crossover study","volume":"17","author":"Ohara","year":"2021","journal-title":"Res. Soc. Adm. Pharm."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMp1011512","article-title":"A flood of opioids, a rising tide of deaths","volume":"363","author":"Okie","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.17992\/lbl.2021.10.654","article-title":"Changes in prescriptions on opioids in primary health care during the years 2008-2017","volume":"107","author":"Olafsdottir","year":"2021","journal-title":"Laeknabladid"},{"key":"B31","doi-asserted-by":"publisher","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: Case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1003709","DOI":"10.1371\/journal.pmed.1003709","article-title":"Mortality and concurrent use of opioids and hypnotics in older patients: A retrospective cohort study","volume":"18","author":"Ray","year":"2021","journal-title":"PLoS Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/jppr.1626","article-title":"Deprescribing tools: A review of the types of tools available to aid deprescribing in clinical practice","volume":"50","author":"Reeve","year":"2020","journal-title":"J. Pharm. Pract. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e038692","DOI":"10.1136\/bmjopen-2020-038692","article-title":"Concurrent use of opioids and benzodiazepines\/Z-drugs in alberta, Canada and the risk of hospitalisation and death: A case cross-over study","volume":"10","author":"Sharma","year":"2020","journal-title":"BMJ Open"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/pds.5201","article-title":"Trends in fall-related mortality and fall risk increasing drugs among older individuals in the United States, 1999\u20132017","volume":"30","author":"Shaver","year":"2021","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B36","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1526-4637.2010.00870.x","article-title":"Benzodiazepines predict use of opioids \u2013 A follow-up study of 17, 074 men and women","volume":"11","author":"Skurtveit","year":"2010","journal-title":"Pain Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: Retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"key":"B38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11916-010-0171-1","article-title":"Opioid-induced hyperalgesia: Clinically relevant or extraneous research phenomenon?","volume":"15","author":"Tompkins","year":"2011","journal-title":"Curr. Pain Headache Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.bja.2018.02.022","article-title":"Association of opioid prescribing practices with chronic pain and benzodiazepine co-prescription: A primary care data linkage study","volume":"120","author":"Torance","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1111\/bcp.13244","article-title":"Psychotropics and weak opioid analgesics in plasma samples of older hip fracture patients \u2013 detection frequencies and consistency with drug records","volume":"83","author":"Waade","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1001\/jama.2021.15255","article-title":"Association of tramadol vs codeine prescription dispensation with mortality and other adverse clinical outcomes","volume":"326","author":"Xie","year":"2021","journal-title":"JAMA"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e2028557","DOI":"10.1001\/jamanetworkopen.2020.28557","article-title":"Association between benzodiazepine use with or without opioid use and all-cause mortality in the United States, 1999-2015","volume":"3","author":"Xu","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/j.1532-2149.2014.496.x","article-title":"Changes in trends and pattern of strong opioid prescribing in primary care","volume":"18","author":"Zin","year":"2014","journal-title":"Eur. J. Pain"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.932380\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T08:56:49Z","timestamp":1662454609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.932380\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":41,"alternative-id":["10.3389\/fphar.2022.932380"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.932380","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"article-number":"932380"}}